Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 190NETWORK 10NIH 4OTHER_GOV 2INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 267Neoplasms 176Colorectal Neoplasms 133Stomach Neoplasms 107Uterine Cervical Neoplasms 95Carcinoma, Non-Small-Cell Lung 89Prostatic Neoplasms 82Lung Neoplasms 78Carcinoma, Hepatocellular 72Rectal Neoplasms 64Ovarian Neoplasms 54Esophageal Neoplasms 53Pancreatic Neoplasms 52Colonic Neoplasms 52Recurrence 43Multiple Myeloma 39Neoplasm Metastasis 38Head and Neck Neoplasms 37Endometrial Neoplasms 36Precursor Cell Lymphoblastic Leukemia-Lymphoma 35Motor Activity 34Melanoma 33Polycystic Ovary Syndrome 32Lymphoma 32Urinary Bladder Neoplasms 31Leukemia, Myeloid, Acute 30Thyroid Neoplasms 29Small Cell Lung Carcinoma 28Nasopharyngeal Carcinoma 25Lymphoma, Non-Hodgkin 25

Interventions

Biomarkers 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Cardiotoxicity × Clear all
NCT06340516 2024-04-01

NT-proBNP to Assess Trastuzumab-induced Cardiotoxicity

Vastra Gotaland Region

Phase NA Recruiting
700 enrolled
Breast

Breast Neoplasms, Cardiotoxicity

NCT02605512 2023-11-08

BACCARAT

Institut de Radioprotection et de Surete Nucleaire

Phase NA Completed
118 enrolled
Breast

Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡